Global Sjogren’s Syndrome market is anticipated to grow at a CAGR of 4.6% during the forecast period. Sjogren’s syndrome is a disorder of the human immune system whereby it affects the parts of the body that produces fluids such as saliva, tears. It’s a long- term condition that affects one’s daily life and is more common in women than men that usually starts at age 40 to 60. Sjogren also affects the other parts of the body such as kidneys, joints, lungs, nerves, blood vessels. The treatment focuses on relieving the symptoms such as fiving artificial tears for dry eyes, sucking sugar free candies and drinking gallons of water for dry mouth along with taking some medicines. The factors contributing to the market growth include a growing population with several diseases that can cause Sjogren’s syndrome and increasing demand for advanced treatment for Sjogren’s syndrome. Other factors include increased use of contact lens that leads to dryness of eyes, unhealthy lifestyle adoption, increased advanced treatment of eye diseases and growing diseases like rheumatoid arthritis and lupus are propelling the growth of the market.

However, a lack of awareness among the population about Sjogren’s syndrome restrains the growth of the market. Further lack of proper cure treatments is also projected to hamper the growth of the market. Currently, available treatment options are either ineffective in patients with the following syndrome or only relieve the symptoms. Increasing lab automation rates and technological advances will bring upon opportunities for the growth of the market. Additionally, rising government initiatives such as the North American Rheumatoid Arthritis consortium are educating healthcare professionals and patients regarding the diagnosis and its treatment will boost the growth of the Sjogren’s syndrome market. 

Segmental Outlook 

The global Sjogren’s syndrome market is segmented based on the test, drug type and type. based on test market are segmented blood test, Eye test, imaging test and biopsy. Based on a Drug type, the market is segmented into pilocarpine, cyclosporine, hydroxychloroquine, and immunosuppressive agents. On the basis of type, the market is segmented into primary Sjögren’s syndrome and secondary Sjögren’s syndrome.

Global Sjogren’s Syndrome Market Share by Type, 2020(%)

Secondary Sjogren’s Syndrome Segment is Anticipated to Dominate the Global Sjögren’s Syndrome Market

Secondary Sjögren’s Syndrome is projected to hold a significant share in the global Sjögren’s Syndrome market. The factors contributing to the market growth include the growing prevalence of autoimmune diseases such as rheumatoid arthritis. One of the most common causes of secondary Sjogren’s syndrome include rheumatoid arthritis.  This kind of diagnosis has the following conditions including primary biliary cholangitis, lupus, scleroderma and others. In secondary Sjogren’s syndrome, the doctor will be going through complete medical history and conduct a physical exam. The diagnosis will be including blood work that usually looks for proteins and markers specific to Sjogren’s. It also includes a lower lip biopsy to look for clusters of inflammatory cells. 

Regional Outlook

The global Sjogren’s Syndrome Market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America and Europe have a significant contribution to the global Sjogren’s Syndrome acid market. The growth of the market mainly driven due to the increasing number of autoimmune diseases such as rheumatoid arthritis, lupus, growing demand for advanced treatments solutions for such diseases and increasing prevailing rates of Sjogren’s syndrome in the region.  

Asia-Pacific will Have Considerable Growth in the Global Sjogren’s Syndrome Market

Asia Pacific region is forecasted to exhibit rapid growth of Sjogren’s syndrome market due to rising healthcare infrastructure in the region, the rise of diagnosis of Sjogren’s disease, and increasing government expenditure in the healthcare sector are driving the growth of the Sjogren’s syndrome market in the region. According to Sage publications 2019, almost 68.59% of Chinese patients had dry eye prevalence, and 86.5% had dry mouth prevalence in Chinese patients additionally 6.9% of Chinese patients had arthritis. Further, the increasing prevalence of Sjogren’s syndrome and the rise of such diagnosis also drive the growth of the market. However, lack of proper treatment options, lack of awareness and affordability are the factors restraining the growth of the market in underdeveloped countries such as the Middle East and Africa. 

Market Players Outlook

The key players of the Sjogren’s Syndrome market include AbbVie Inc., Amgen Inc., Argentis Pharmaceuticals, LLC, AstraZeneca PLC, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers, and acquisitions, collaborations, and new product launch, to stay competitive in the market. For instance, in July 2020, UniQuest partnered with CSL Ltd for developing and commercializing its antigen immune tolerance induction technology for treating Sjogren’s syndrome. The main purpose of this collaboration was to identify liposome-encapsulated antigen candidates for Sjogren’s syndrome and then shepherd the lead candidate towards its clinical trials. This technology has the potential to treat patients suffering from autoimmune diseases. 

The Report Covers

• Market value data analysis of 2020 and forecast to 2027.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global Sjogren’s Syndrome Acids 
• market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.